AbbVie Maintains Dividend as ABBV Stock Navigates Humira Biosimilar Competition
AbbVie maintains its position as a leading Dividend Aristocrat in the pharmaceutical sector, offering income investors a reliable payout amid the largest patent cliff in the company’s history. The North Chicago-based biopharmaceutical giant faces accelerating
AbbVie Maintains Dividend as ABBV Stock Navigates Humira Biosimilar Competition Read More »
